4th Quarter - Report
FEDERAL STREET STRATEGIES, LLC for BIOGEN, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment. H.R. 7667 - Food and Drug Amendments Act of 2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE New | Executive Director, Congressional Black Caucus; Deputy Assistant Secretary of Labor, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; and Special Assistant, U.S. Secretary of Labor, Department of Labor. |
| ANDREW JONES New | Legislative Counsel, U.S. Representative Ruben Hinojosa; Legislative Director and Counsel, U.S. Representative Ben Ray Lujan |
Medicare/Medicaid MMM
Issues related to Alzheimer's Disease and treatment. H.R.5376 - Inflation Reduction Act of 2022 Issues related to Mental Health treatment
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE New | Executive Director, Congressional Black Caucus; Deputy Assistant Secretary of Labor, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; and Special Assistant, U.S. Secretary of Labor, Department of Labor. |
| ANDREW JONES New | Legislative Counsel, U.S. Representative Ruben Hinojosa; Legislative Director and Counsel, U.S. Representative Ben Ray Lujan |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.